People with thyroid eye disease receiving infusions of the insulin-like growth factor-1 receptor veligrotug report improved ...
The refusal of blood transfusions by Jehovah’s Witnesses poses a major challenge in treating acute myeloid leukaemia (AML), ...
Key points A 68-year-old woman from rural Ontario arrived at her local emergency department with worsening palpitations. Her medical history included breast cancer treated with surgical resection and ...
On August 7, 2025, the Food and Drug Administration announced that it would be demanding the elimination of natural thyroid treatment, otherwise known as desiccated thyroid extract (DTE) or natural ...
Hypothyroidism is a condition in which your thyroid gland, which controls your metabolism and energy, doesn’t produce enough thyroid hormone. If you have this condition, your doctor might prescribe ...
A myasthenia gravis treatment revolution has taken place in the past four years, spurred by an initial approval for argenx’s ...
Novo Nordisk today announced new data on the investigational oral semaglutide 25 mg will be among 23 abstracts to be ...
Eat smart for your thyroid and immunity: learn which foods pack selenium safely, how much you really need, and why moderation ...
Hosted on MSN
Introducing the Learjet 75 Liberty
The new Learjet 75 Liberty redefines the iconic Learjet brand and features the segment’s first private Executive Suite. Harnessing American know-how and efficiency, the Learjet 75 Liberty offers more ...
Key points A 55-year-old man with a left-sided goiter and local compression symptoms presented to our endocrinology clinic. He did not have dysphagia, dyspnea, or hoarseness. All laboratory results, ...
Merck and Eisai Announce WELIREG® Plus LENVIMA® Met Primary Endpoint of PFS in Certain Previously Treated Patients With ...
Merck Announces KEYTRUDA Plus WELIREG Met Primary Endpoint of DFS in Certain Patients With Clear Cell Renal Cell Carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results